IMV Acciones en circulación
¿Qué es el Acciones en circulación de IMV?
El Acciones en circulación de IMV, Inc. es 8.237M
¿Cuál es la definición de Acciones en circulación?
Las acciones en circulación son todas las acciones de una corporación o de un activo financiero que han sido autorizadas, emitidas y compradas por los inversionistas y son retenidas por ellos.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Acciones en circulación de compañías en Sector Health Care en TSX en comparadas con IMV
¿Qué hace IMV?
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.
Empresas con acciones en circulación similar a IMV
- LifeSci Acquisition tiene Acciones en circulación de 8.205M
- Deal Pro Capital Corp tiene Acciones en circulación de 8.207M
- Vivoryon Therapeutics AG tiene Acciones en circulación de 8.208M
- Kuros Biosciences AG tiene Acciones en circulación de 8.209M
- Buzz Capital 2 tiene Acciones en circulación de 8.220M
- Devoteam SA tiene Acciones en circulación de 8.226M
- IMV tiene Acciones en circulación de 8.237M
- Prithvi Exchange (India) tiene Acciones en circulación de 8.250M
- California BanCorp tiene Acciones en circulación de 8.251M
- Cavco Industries Inc tiene Acciones en circulación de 8.253M
- Titan Biotech tiene Acciones en circulación de 8.264M
- Enertime SA tiene Acciones en circulación de 8.266M
- CRCAM Paris & Ile de France tiene Acciones en circulación de 8.267M